Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TRLV is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
23 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
125 filers reported a long position in TRLV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| AdvisorShares Investments LLC | $104.6M | 10.6M | New |
| NOMURA HOLDINGS INC | $49.8M | 5.1M | New |
| CANTOR FITZGERALD, L. P. | $36.9M | 3.8M | New |
| Marex Group Ltd | $31.9M | 3.3M | New |
| ING GROEP NV | $26.2M | 2.7M | New |
| JANE STREET GROUP, LLC | $11.9M | 1.2M | New |
| PICTON MAHONEY ASSET MANAGEMENT | $8.2M | 838.1K | New |
| Anson Funds Management LP | $5.6M | 524.5K | New |
| iA Global Asset Management Inc. | $5.1M | 523K | New |
| Verition Fund Management LLC | $4.9M | 500K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.